Amarantus Bioscience Holdings, Inc. (AMBS: OTC Pink Current) | Amarantus Subsidiary MANF Therapeutics Announces Publication in Science Magazine of Positive Animal Data for MANF in Treatment of Retinal Damage and Issuance of Retinal Patent in Japan Covering MANF and CDNF
(0)
(0)